Literature DB >> 1650766

Antibodies to gag gene coded polypeptides of type D retroviruses in healthy people from Guinea-Bissau.

V A Morozov1, F Saal, A Gessain, A Terrinha, J Périès.   

Abstract

Antibodies to proteins of Mason-Pfizer monkey virus (M-PMV) were screened in sera from 61 healthy donors living in Guinea-Bissau (4 HIV-1 and HIV-2 antibody positive HIV = human immunodeficiency virus), from 19 healthy French European blood donors, and from 9 French patients with induced immunodeficiency prior to bone marrow transplantation (all HIV-1 antibody negative). In 30 (49%) of the African sera tested, antibodies reacting against p27 and/or p14 were detected by western blot. Some of these cases were confirmed to be positive using radioimmuno precipitation assay. Only one serum from a French blood donor was detected by western blot to be slightly positive against p27 M-PMV. Thirty-two sera screened for M-PMV were also tested for squirrel monkey retrovirus by western blot. In eight (25%) sera antibodies at least against p36 were detected. Among squirrel monkey retrovirus positive sera, three were also positive with p27 M-PMV. The other five were found to be M-PMV negative.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1650766     DOI: 10.1159/000150207

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  3 in total

1.  Evidence of infection with simian type D retrovirus in persons occupationally exposed to nonhuman primates.

Authors:  N W Lerche; W M Switzer; J L Yee; V Shanmugam; A N Rosenthal; L E Chapman; T M Folks; W Heneine
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Identification of human type D retrovirus as a contaminant in a neuroblastoma cell line.

Authors:  K Asikainen; M Vesanen; T Kuittinen; A Vaheri
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

3.  Isolation of a type D retrovirus from B-cell lymphomas of a patient with AIDS.

Authors:  R C Bohannon; L A Donehower; R J Ford
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.